[ad_1]
Moderna’s stock price has soared by 250% because the company’s vaccine has helped countries around the world to get out of the haze of the new crown epidemic to a certain extent.
S&P Dow Jones Indices announced after the market on Thursday that Moderna will be included in the S&P 500 index on July 21, replacing the current Alexion Pharmaceuticals. Affected by this news, Moderna’s share price surged by more than 10% on Friday, and the share price refreshed its closing record high of US$286.43, with a market value of over US$115 billion.
[ad_2]
Source link